A detailed history of Toroso Investments, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Toroso Investments, LLC holds 20,544 shares of ALNY stock, worth $5.17 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
20,544
Previous 20,544 -0.0%
Holding current value
$5.17 Million
Previous $5.65 Million -0.0%
% of portfolio
0.07%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$233.81 - $287.01 $2.06 Million - $2.53 Million
8,811 Added 75.1%
20,544 $5.65 Million
Q2 2024

Aug 14, 2024

BUY
$143.31 - $247.0 $208,086 - $358,644
1,452 Added 14.12%
11,733 $2.85 Million
Q1 2024

May 15, 2024

BUY
$146.51 - $198.2 $1.12 Million - $1.52 Million
7,660 Added 292.25%
10,281 $1.54 Million
Q4 2023

Feb 14, 2024

BUY
$151.41 - $196.57 $52,085 - $67,620
344 Added 15.11%
2,621 $501,000
Q3 2023

Nov 15, 2023

BUY
$170.77 - $211.65 $9,563 - $11,852
56 Added 2.52%
2,277 $403,000
Q2 2023

Aug 14, 2023

SELL
$185.01 - $212.05 $291,205 - $333,766
-1,574 Reduced 41.48%
2,221 $422,000
Q1 2023

May 15, 2023

SELL
$182.66 - $235.53 $86,398 - $111,405
-473 Reduced 11.08%
3,795 $760,000
Q4 2022

Feb 15, 2023

BUY
$185.53 - $241.31 $338,963 - $440,873
1,827 Added 74.85%
4,268 $1.01 Million
Q3 2022

Nov 23, 2022

BUY
$138.54 - $232.0 $87,695 - $146,856
633 Added 35.01%
2,441 $489,000
Q2 2022

Aug 15, 2022

SELL
$120.42 - $169.29 $71,649 - $100,727
-595 Reduced 24.76%
1,808 $264,000
Q1 2022

May 20, 2022

BUY
$127.18 - $173.91 $28,233 - $38,608
222 Added 10.18%
2,403 $392,000
Q4 2021

Feb 16, 2022

SELL
$159.56 - $209.29 $30,795 - $40,392
-193 Reduced 8.13%
2,181 $369,000
Q3 2021

Nov 15, 2021

BUY
$169.75 - $207.73 $63,316 - $77,483
373 Added 18.64%
2,374 $448,000
Q2 2021

Aug 13, 2021

BUY
$128.63 - $176.89 $257,388 - $353,956
2,001 New
2,001 $339,000

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Toroso Investments, LLC Portfolio

Follow Toroso Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Toroso Investments, LLC with notifications on news.